共 50 条
Azapteridine inhibitors of hepatitis C virus RNA-dependent RNA polymerase
被引:2
|作者:
Middleton, T.
[1
]
Lim, H. B.
[1
]
Montgomery, D.
[1
]
Rockway, T.
[1
]
Liu, D.
[1
]
Klein, L.
[1
]
Qin, W.
[1
]
Harlan, J. E.
[1
]
Kati, W. M.
[1
]
Molla, A.
[1
]
机构:
[1] Abbott Labs, Dept R4CQ, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
关键词:
hepatitis C virus;
RNA-dependent RNA polymerase;
azapteridine;
toxoflavin;
D O I:
10.2174/157018007778992937
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
A high throughput screen was conducted to identify inhibitors of the RNA-dependent RNA polymerase (RdRp) of HCV. One of the classes identified was related to toxoflavin, a naturally occurring antibiotic. These compounds were potent inhibitors of HCV RdRp, with optimization of the initial hits giving compounds with half-maximal inhibition at 200 nM However, binding studies indicated that a physical interaction with RdRp was too weak to be detected. Inhibition was dependent on reducing agent, implicating the flavin core as essential to the inhibitory properties of these compounds. The accumulation of the inhibitory species occurred over a time span of I to 2 hours, the period of time required for oxidation of a 10 to 100-fold excess of DTT by the flavin. These results indicate that the inhibitory species is likely to be a chemically reactive species resulting from the interaction of the flavin and DTT. Human RNA polymerase II was also sensitive to inhibition by these toxoflavin-like compounds. While this class of inhibitors has generated interest as antibacterial, antifungal and antitumor agents, their use has been limited by toxicity. These results provide a potential mechanism to explain the toxicity of these compounds.
引用
收藏
页码:1 / 8
页数:8
相关论文